A phase II trial of 5-fluorouracil and 1-leucovorin in patients with metastatic colorectal cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 19, Issue 1, 1996, Pages 26-31

  Erlichman, C ^a,j   Fine, S ^b   Kerr, I ^c   Hoffmann, W ^d   Gorg, C ^e   Schmoll, H J ^f   Preusser, P ^g   Thuerlimann, B ^h   Gustavsson, B ⁱ  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b CREDIT VALLEY HOSPITAL   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d City Hospital Leverkusen   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^h CANTONAL HOSPITAL ST GALLEN   (Switzerland)

ⁱ SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^j MAYO CLINIC   (United States)

more..

Author keywords

5FU; Colorectal metastasis Phase II; Leucovorin

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DIARRHEA; DRUG EFFICACY; FEMALE; GRANULOCYTOPENIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; NAUSEA; PHASE 2 CLINICAL TRIAL; STOMATITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIDOTES; ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; STEREOISOMERISM; SURVIVAL ANALYSIS;

EID: 0030048024     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199602000-00006     Document Type: Article

References (17)

1. Erlichman C, Fine S, Wong A, Elhakim T. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 1988;6:469-75.
2. Poon MA, O'Connell MJ, Wieand HS, et al. Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 1991;9:1967-72.
3. The Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 1992;10:896-90.
4. Yin M-B, Zakrzewski SF, Hakala MT. Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil. Mol Pharmacol 1983;23:190-7.
5. Keyomarsi K, Moran RG. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells. Cancer Res 1986;16:5229-35.
6. Houghton JA, Williams LG, Cheshire PJ, Wainer IW, Jadaud P, Houghton PJ. Influence of dose of [6RS] leucovorin on reduced folate pools and 5-fluorouracil-mediated thymidylate synthase inhibition in human colon adenocarcinoma xenografts. Cancer Res 1990;50:3940-6.
7. Sirotnak FM, Chello PL, Moccio DM, et al. Stereospecificity at carbon 6 of formyltetrahydrofolate as a competitive inhibitor of transport and cytotoxicity of methotrexate in vitro. Biochem Pharmacol 1979;28:2993-7.
8. Bertrand R, Jolivet J. Lack of interference by the unnatural isomer of 5-formyltetrahydrofolate with the effects of the natural isomer in leucovorin preparations. J Natl Cancer Inst 1989;81:1175-8.
9. StatXact, version 2.02, users' manual. Cambridge, MA: Cytel Software Corporation, 1991.
10. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Soc 1958;53:457-81.
11. SAS Users' guide: statistics, version 5.0. Cary, North Carolina: SAS Institute, 1985.
12. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.
13. Miller RG Jr. Survival analysis. New York: John Wiley, 1981.
14. Machover D, Grison X, Goldschmidt E, et al. Fluorouracil combined with pur (6S)-stereisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma, a phase I-II study. J Natl Cancer Inst 1992;84:321-7.
15. Schilsky RL, Choi KE, Vokes EE. Clinical pharmacology of the stereoisomers of leucovorin during oral dosing. Cancer 1989;63: 1018-21.
16. Laufman LR, Bukowski RM, Collier MA, et al. A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancer. J Clin Oncol 1993;11:1883-93.
17. Blijham GH, Wagener DJ, van Oosterom AT, et al. Phase II study of high-dose 5-fluorouracil (FU) with oral leucovorin (LV) in advanced colorectal cancer. Ann Oncol 1990;1(suppl):45.